Table 3.
Analysis of haplotypes consisting of IFI16 polymorphisms in schizophrenia patients and control subjects
Haplotype |
Frequency |
OR (95% CI) | p-value | |||
---|---|---|---|---|---|---|
rs1465175 | rs3754464 | rs1417806 | Control | Schizophrenia | ||
G | A | A | 0.584 | 0.569 | 1 | - |
G | G | A | 0.161 | 0.230 | 1.42 (1.06–1.90) | 0.018* |
T | A | C | 0.195 | 0.143 | 0.75 (0.55–1.03) | 0.072 |
G | A | C | 0.024 | 0.030 | 1.17 (0.58–2.35) | 0.67 |
T | A | A | 0.021 | 0.021 | 0.94 (0.42–2.10) | 0.88 |
G | G | C | 0.016 | 0.007 | 0.55 (0.15–2.00) | 0.36 |
statistically significant values (p<0.05).
IFI16: IFN-γ-inducible protein 16, OR: odds ratios, CI: confidence intervals